[ET Net News Agency, 23 February 2018] Nomura lifted its target price for China Vanke
(02202) to HK$44.7 from HK$32.5, and reiterated its "buy" rating.
The research house expects close to 40% core earnings growth for Vanke's FY2017 results,
driven by 20% revenue growth and 3pp gross margin improvement. For 2018 sales, Nomura
expects at least 20% growth to CNY635bn, supported by abundant saleable resources of 60mn
sqm at an ASP of CNY15k/sqm, implying 70% sell-through rate.
In January, Vanke achieved CNY68bn sales, a historical high. Cash collection ratio was
very high in 2017 at 95%, and management is confident of it remaining at a high level in
2018F despite the credit tightening environment, thanks to its leading industry position.
(KL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02202 CHINA VANKE
Nominal 
3.920 +0.070 (+1.818%) Others
23/02/2018 14:19
[I-bank focus]Nomura lifts China Vanke (02202) to HK$44.7
| Remark: | Real time quote last updated: 25/04/2024 17:05 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |